Stem Cells
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online August 21, 2008
Stem Cells Vol. 26 No. 11 November 2008, pp. 2902 -2911
doi:10.1634/stemcells.2008-0090; www.StemCells.com
© 2008 AlphaMed Press

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
2008-0090v1
2008-0090v2
26/11/2902    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carraro, G.
Right arrow Articles by Warburton, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carraro, G.
Right arrow Articles by Warburton, D.

TISSUE-SPECIFIC STEM CELLS

Human Amniotic Fluid Stem Cells Can Integrate and Differentiate into Epithelial Lung Lineages

Gianni Carraroa, Laura Perina, Sargis Sedrakyana, Stefano Giuliania, Caterina Tiozzob, Jooeun Leea, Gianluca Turcatela, Stijn P. De Langhea, Barbara Driscolla, Saverio Belluscia, Parviz Minoob, Anthony Atalac, Roger Edward De Filippoa, David Warburtona

aDevelopmental Biology, Regenerative Medicine and Surgery Program, Saban Research Institute, Children's Hospital Los Angeles, Keck School of Medicine and School of Dentistry, Los Angeles, California, USA;
bWomen's & Children's Hospital, Keck School of Medicine, University of Southern California, Los Angeles, California;
cWake Forest Institute for Regenerative Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina

Key Words. Amniotic fluid stem cells • Lung injury • Tissue repair • Regenerative medicine

Correspondence: Correspondence: David Warburton, DSc, M.D., FRCP, FRCS, Developmental Biology, Regenerative Medicine and Surgery Program, Saban Research Institute, Children's Hospital Los Angeles, Keck School of Medicine and School of Dentistry, 4661 Sunset Boulevard MS 35, Los Angeles, California 90027, USA. Telephone: 323-669-5422; Fax: 323-671-3613; e-mail: dwarburton{at}chla.usc.edu

Received on January 29, 2008; accepted for publication on August 5, 2008.

First published online in STEM CELLS EXPRESS  August 21, 2008.


A new source of stem cells has recently been isolated from amniotic fluid; these amniotic fluid stem cells have significant potential for regenerative medicine. These cells are multipotent, showing the ability to differentiate into cell types from each embryonic germ layer. We investigated the ability of human amniotic fluid stem cells (hAFSC) to integrate into murine lung and to differentiate into pulmonary lineages after injury. Using microinjection into cultured mouse embryonic lungs, hAFSC can integrate into the epithelium and express the early human differentiation marker thyroid transcription factor 1 (TTF1). In adult nude mice, following hyperoxia injury, tail vein-injected hAFSC localized in the distal lung and expressed both TTF1 and the type II pneumocyte marker surfactant protein C. Specific damage of Clara cells through naphthalene injury produced integration and differentiation of hAFSC at the bronchioalveolar and bronchial positions with expression of the specific Clara cell 10-kDa protein. These results illustrate the plasticity of hAFSC to respond in different ways to different types of lung damage by expressing specific alveolar versus bronchiolar epithelial cell lineage markers, depending on the type of injury to recipient lung.

Disclosure of potential conflicts of interest is found at the end of this article.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS

Copyright © 2008 by AlphaMed Press.